Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.-Reference-Cited by-同舟云学术

Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.

Published:1978-12-01 Issue:12 Volume:19 Page:1131-1135
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Uribe M,Schalm S W,Summerskill W H,Go V L

Publisher

BMJ

Subject

Gastroenterology

Reference17 articles.

1. 11 fl-hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro;Bush, I.E.;Advances in the Biosciences,1969

2. Metabolism of 11oxygenated steroids;Bush, I.E.; Mahesh, V.B.,1964

3. Some 1-dehydro and 9-a-fluoro steroids;Gibaldi, M.; Boyes, R.N.; Feldman, S.;Biochemical Journal; Influence of first pass effect on availability of drugs on oral administration,1971

4. Route of administration and drug metabolism;Gibaldi, M.; Feldman, S.;European Journal of Pharmacology,1972

5. First-pass metabolism of nortriptyline in man;Gram, L.F.; Overo, K.F.;Clinical Pharmacology and Therapeutics,1976

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of An Oral Bioavailability Prediction Model Based on Machine Learning for Evaluating Molecular Modifications;Journal of Pharmaceutical Sciences;2024-05

2. A narrative review of the principal glucocorticoids employed in cancer;Seminars in Oncology;2022-12

3. Serum triamcinolone levels during intensive, inpatient wet‐dressing therapy;Clinical and Experimental Dermatology;2020-05-14

4. Pharmacokinetics of Total and Unbound Prednisone and Prednisolone in Stable Kidney Transplant Recipients With Diabetes Mellitus;Therapeutic Drug Monitoring;2014-08

5. Acute and Acute Severe (Fulminant) Autoimmune Hepatitis;Digestive Diseases and Sciences;2012-10-23